Global Nerve Repair and Regeneration Devices Market to Reach $12.9 Billion by 2027 – Yahoo Finance

ReportLinker

Abstract: Whats New for 2022?? Global competitiveness and key competitor percentage market shares. Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nerve Repair and Regeneration Devices Industry" - https://www.reportlinker.com/p05957490/?utm_source=GNW

Online interactive peer-to-peer collaborative bespoke updates

Access to our digital archives and MarketGlass Research Platform

Complimentary updates for one yearGlobal Nerve Repair and Regeneration Devices Market to Reach $12.9 Billion by 2027 - In the changed post COVID-19 business landscape, the global market for Nerve Repair and Regeneration Devices estimated at US$6.6 Billion in the year 2020, is projected to reach a revised size of US$12.9 Billion by 2027, growing at aCAGR of 10% over the period 2020-2027. Neurostimulation & Neuromodulation Devices, one of the segments analyzed in the report, is projected to record 9.7% CAGR and reach US$10.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biomaterials segment is readjusted to a revised 11.7% CAGR for the next 7-year period. - The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 13% CAGR - The Nerve Repair and Regeneration Devices market in the U.S. is estimated at US$2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2027 trailing a CAGR of 13% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 8.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Select Competitors (Total 61 Featured) Abbott Laboratories, Inc. AxoGen, Inc. Boston Scientific Corporation Integra LifeSciences Corporation LivaNova, PLC Medtronic plc NeuroPace, Inc. Nevro Corporation. Orthomed S.A.S. Polyganics B.V. Stryker Corporation Synapse Biomedical Inc. Synovis Micro Companies Alliance, Inc.

Read the full report: https://www.reportlinker.com/p05957490/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY 1. GLOBAL MARKET OVERVIEW Impact of Covid-19 and a Looming Global Recession 2020 Marked as a Year of Disruption & Transformation World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022 Global Nerve Repair & Regeneration Market Buckles under COVID- 19 Strain Covid-19 Patients in Prone Position Suffering Nerve Damage Bodes Well for Market Growth Nerve Repair and Regeneration Market Set for a Robust Growth Neurostimulation & Neuromodulation Devices Hold Commanding Slot in Nerve Repair & Regeneration Market Biomaterials to Exhibit Rapid Growth Nerve Repair and Regeneration Market by Application US and Europe Dominate the Market Asia-Pacific and other Emerging Regions Display Impressive Growth Potential Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS High Incidence of Neurological Disorders: A Key Market Driver Annual Incidence of Adult-Onset Neurologic Disorders in the US Effects of COVID-19 on the Nervous System Sheds Focus on Neuromodulation Applications Increasing Cases of Peripheral Nerve Injuries Drive the Nerve Repair and Regeneration Market Growing Number of Vehicular Accidents Drive the Peripheral Nerve injuries Repair Market Rising Geriatric Population and Subsequent Growth in Prevalence Of Neurological Disorders Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices Global Alzheimers Prevalence by Age Group Diagnosed Prevalence Cases of Parkinson?s Disease Across Select Countries Global DBS Market by Leading Player (2020E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott Select Available Deep Brain Stimulation Devices Available in the Market Intensified Research Activity Across Various Neural Disciplines Induces Additional Optimism Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices Epilepsy Incidence by Type (2019): Percentage Share Breakdown for Idiopathic and Symptomatic Epilepsy Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices Recent Developments in Spinal Cord Injury Treatment Biomaterials (Nerve Conduits and Nerve Wraps) to Witness Rapid Growth New Biomaterials Pave the Way for Innovative Neurodegeneration Therapies Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury Innovative Nerve Conduits from Stryker TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices Nerve Grafts for Bridging Larger Nerve Gaps Role of Nerve Grafting in Treatment of Peripheral Nerve Injuries FDA-approved Nerve Tubes for Peripheral Nerve Repair

4. GLOBAL MARKET PERSPECTIVE Table 1: World Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Nerve Repair and Regeneration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Nerve Repair and Regeneration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for Neurostimulation & Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Neurostimulation & Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Neurostimulation & Neuromodulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for Biomaterials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Biomaterials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Biomaterials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for Neurostimulation & Neuromodulation Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Neurostimulation & Neuromodulation Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Neurostimulation & Neuromodulation Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for Neurorrhaphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Neurorrhaphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Neurorrhaphy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for Nerve Grafting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Nerve Grafting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Nerve Grafting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Impact of Covid-19 and a Looming Global Recession

III. MARKET ANALYSIS

UNITED STATES Nerve Repair and Regeneration Devices Market Presence - Strong/ Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) Table 28: USA Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Nerve Repair and Regeneration Devices by Product - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Devices and Biomaterials for the Years 2012, 2021 & 2027

Table 31: USA Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Nerve Repair and Regeneration Devices by Application - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the Years 2012, 2021 & 2027

Table 34: USA Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Nerve Repair and Regeneration Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgery Centers for the Years 2012, 2021 & 2027

CANADA Table 37: Canada Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Nerve Repair and Regeneration Devices by Product - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Devices and Biomaterials for the Years 2012, 2021 & 2027

Table 40: Canada Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Nerve Repair and Regeneration Devices by Application - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the Years 2012, 2021 & 2027

Table 43: Canada Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Nerve Repair and Regeneration Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgery Centers for the Years 2012, 2021 & 2027

JAPAN Nerve Repair and Regeneration Devices Market Presence - Strong /Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) Table 46: Japan Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 48: Japan 15-Year Perspective for Nerve Repair and Regeneration Devices by Product - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Devices and Biomaterials for the Years 2012, 2021 & 2027

Table 49: Japan Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Nerve Repair and Regeneration Devices by Application - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the Years 2012, 2021 & 2027

Table 52: Japan Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Nerve Repair and Regeneration Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgery Centers for the Years 2012, 2021 & 2027

CHINA Nerve Repair and Regeneration Devices Market Presence - Strong /Active/Niche/Trivial - Key Competitors in China for 2022 (E) Table 55: China Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 57: China 15-Year Perspective for Nerve Repair and Regeneration Devices by Product - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Devices and Biomaterials for the Years 2012, 2021 & 2027

Table 58: China Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Nerve Repair and Regeneration Devices by Application - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the Years 2012, 2021 & 2027

Table 61: China Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Nerve Repair and Regeneration Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgery Centers for the Years 2012, 2021 & 2027

EUROPE Nerve Repair and Regeneration Devices Market Presence - Strong/ Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) Table 64: Europe Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Nerve Repair and Regeneration Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Nerve Repair and Regeneration Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027

Table 67: Europe Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Nerve Repair and Regeneration Devices by Product - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Devices and Biomaterials for the Years 2012, 2021 & 2027

Table 70: Europe Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Nerve Repair and Regeneration Devices by Application - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the Years 2012, 2021 & 2027

Table 73: Europe Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Nerve Repair and Regeneration Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgery Centers for the Years 2012, 2021 & 2027

FRANCE Nerve Repair and Regeneration Devices Market Presence - Strong/ Active/Niche/Trivial - Key Competitors in France for 2022 (E) Table 76: France Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for Nerve Repair and Regeneration Devices by Product - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Devices and Biomaterials for the Years 2012, 2021 & 2027

Table 79: France Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Nerve Repair and Regeneration Devices by Application - Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Nerve Repair and Regeneration Devices by Application - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for the Years 2012, 2021 & 2027

Table 82: France Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 83: France Historic Review for Nerve Repair and Regeneration Devices by End-Use - Hospitals & Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Nerve Repair and Regeneration Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgery Centers for the Years 2012, 2021 & 2027

GERMANY Nerve Repair and Regeneration Devices Market Presence - Strong/ Active/Niche/Trivial - Key Competitors in Germany for 2022: (E) Table 85: Germany Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Nerve Repair and Regeneration Devices by Product - Neurostimulation & Neuromodulation Devices and Biomaterials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Nerve Repair and Regeneration Devices by Product - Percentage Breakdown of Value Sales for Neurostimulation & Neuromodulation Devices and Biomaterials for the Years 2012, 2021 & 2027

The rest is here:
Global Nerve Repair and Regeneration Devices Market to Reach $12.9 Billion by 2027 - Yahoo Finance

Stem Cell Clinics List | Stem Cells Freak [Last Updated On: May 30th, 2015] [Originally Added On: May 30th, 2015]
Stem Cell Therapy Clinics In Canada | Stem Cell Medical ... [Last Updated On: August 2nd, 2015] [Originally Added On: August 2nd, 2015]
Predatory stem cell clinics are winning the war; what can ... [Last Updated On: September 22nd, 2015] [Originally Added On: September 22nd, 2015]
Stem cell clinics, FDA, and giant, unapproved for-profit ... [Last Updated On: September 25th, 2015] [Originally Added On: September 25th, 2015]
Adult Stem Cell Banks and Clinics Marketing Stem Cell ... [Last Updated On: September 25th, 2015] [Originally Added On: September 25th, 2015]
Stem Cell Clinics : National Multiple Sclerosis Society [Last Updated On: September 29th, 2015] [Originally Added On: September 29th, 2015]
First stem cell treatment for human administered in Atlanta ... [Last Updated On: August 20th, 2016] [Originally Added On: August 20th, 2016]
Hundreds of U.S. clinics are selling unapproved stem cell ... [Last Updated On: August 31st, 2016] [Originally Added On: August 31st, 2016]
Treatment Abroad | Canadian Stem Cell Foundation [Last Updated On: September 18th, 2016] [Originally Added On: September 18th, 2016]
CIRM Alpha Stem Cell Clinic - UCSD Stem Cell Program [Last Updated On: September 18th, 2016] [Originally Added On: September 18th, 2016]
Stem Cell Clinics Questions to Ask - National Multiple ... [Last Updated On: September 23rd, 2016] [Originally Added On: September 23rd, 2016]
Stem Cell Therapy - Cendant Cellular Therapies - Denver ... [Last Updated On: November 30th, 2016] [Originally Added On: November 30th, 2016]
Private clinics' peddling of unproven stem cell treatments is unsafe and unethical - Medical Xpress [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
North Central Texas Stem Cell Clinics in conjunction ... [Last Updated On: July 9th, 2017] [Originally Added On: July 9th, 2017]
Broomfield's Regenexx in merger with Iowa company - Longmont Times-Call [Last Updated On: July 12th, 2017] [Originally Added On: July 12th, 2017]
Dozens of US clinics sell unproven stem cell therapies for heart failure - Fox News [Last Updated On: July 30th, 2017] [Originally Added On: July 30th, 2017]
Stem cell treatment potential in Canada - IMTJ [Last Updated On: August 20th, 2017] [Originally Added On: August 20th, 2017]
FDA cracks on clinics using unapproved stem cell treatments - Pulse Headlines [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
FDA cracks down on clinics selling unapproved stem cell therapies - CBS News [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
FDA to crack down on 'unscrupulous' stem cell clinics ... [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
FDA cracks down on clinics selling unproven stem cell therapies - Gears Of Biz [Last Updated On: September 3rd, 2017] [Originally Added On: September 3rd, 2017]
Canadian clinics begin offering stem-cell treatments ... [Last Updated On: September 3rd, 2017] [Originally Added On: September 3rd, 2017]
Stem Cell Therapy and Its Revolutionary Purposes Guardian ... - Guardian Liberty Voice [Last Updated On: September 4th, 2017] [Originally Added On: September 4th, 2017]
At ClinicalTrials.Gov, Untested Stem Cell Clinics ... [Last Updated On: October 13th, 2017] [Originally Added On: October 13th, 2017]
Adult Stem Cell Therapy in Utah Docere Clinics [Last Updated On: October 18th, 2017] [Originally Added On: October 18th, 2017]
Patients guide to treatments - The Niche [Last Updated On: July 14th, 2018] [Originally Added On: July 14th, 2018]
FDA: Florida Stem Cell Clinic Violates Law | Health News Florida [Last Updated On: September 15th, 2018] [Originally Added On: September 15th, 2018]
Stem cell laws - Wikipedia [Last Updated On: October 17th, 2018] [Originally Added On: October 17th, 2018]
What Stem Cell Clinics Do You Trust? | BioInformant [Last Updated On: November 5th, 2018] [Originally Added On: November 5th, 2018]
Meet Our Doctors - Rejuva Stem Cell Clinic [Last Updated On: December 24th, 2018] [Originally Added On: December 24th, 2018]
FDA Wants To Tighten The Screws On Stem Cell Clinics ... [Last Updated On: December 24th, 2018] [Originally Added On: December 24th, 2018]
Stem cell market: Inside California's flourishing for ... [Last Updated On: December 24th, 2018] [Originally Added On: December 24th, 2018]
Stem cell therapy: FDA investigates clinics offering ... [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
Stem Cell Therapy Chicago Illinois, Buffalo Grove ... [Last Updated On: January 23rd, 2019] [Originally Added On: January 23rd, 2019]
Stem Cell Transplant in Germany: Clinics, Cost, Price ... [Last Updated On: February 15th, 2019] [Originally Added On: February 15th, 2019]
Mayo Clinic finds surprising results on first-ever test of ... [Last Updated On: February 15th, 2019] [Originally Added On: February 15th, 2019]
Stem Cell Clinics - eureka [Last Updated On: February 15th, 2019] [Originally Added On: February 15th, 2019]
Patients fleeced by overseas stem cell clinics? Now it ... [Last Updated On: April 1st, 2019] [Originally Added On: April 1st, 2019]
Stem cell clinics sued | Regenerative Medicine Foundation [Last Updated On: April 1st, 2019] [Originally Added On: April 1st, 2019]
UCLA UCI Alpha Stem Cell Clinic | UCLA Broad Stem Cell Center [Last Updated On: April 1st, 2019] [Originally Added On: April 1st, 2019]
Stem cell clinics make big claims but offer little ... [Last Updated On: April 1st, 2019] [Originally Added On: April 1st, 2019]
Private clinics peddling of unproven stem cell treatments ... [Last Updated On: April 29th, 2019] [Originally Added On: April 29th, 2019]
FDA Mounts Aggressive Push to Regulate Stem-Cell Clinics ... [Last Updated On: May 16th, 2019] [Originally Added On: May 16th, 2019]
'Stem cell' therapies offered at private clinics need to ... [Last Updated On: May 22nd, 2019] [Originally Added On: May 22nd, 2019]
Amyotrophic Lateral Sclerosis (Lou Gehrigs Disease) Treatment Market Size, Status and Growth Opportunities by 2016 2022 - Analytics News [Last Updated On: September 24th, 2019] [Originally Added On: September 24th, 2019]
Global Stem Cell Cartilage Regeneration Market Size, Development Plans and Forecast to 2028 - Analytics News [Last Updated On: September 24th, 2019] [Originally Added On: September 24th, 2019]
Global Canine Stem Cell Therapy Market Data Analysis, Growth, Demand & Forecast 2019-2024: VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus,... [Last Updated On: September 24th, 2019] [Originally Added On: September 24th, 2019]
Opinion: Kudos to Google for banning stem cell ads. Other tech companies should follow - Yahoo News [Last Updated On: September 24th, 2019] [Originally Added On: September 24th, 2019]
Google banned ads for stem cell treatments. Others should follow - STAT [Last Updated On: September 24th, 2019] [Originally Added On: September 24th, 2019]
Better solutions for the replacement of joints - SciTech Europa [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
Tech review: Apps that enhance cellphone battery performance - Newsday [Last Updated On: October 10th, 2019] [Originally Added On: October 10th, 2019]
BEYOND LOCAL: Expert recommends 'path of cautious optimism' about the future of stem cell treatment - NewmarketToday.ca [Last Updated On: October 10th, 2019] [Originally Added On: October 10th, 2019]
BEYOND LOCAL: Expert recommends 'path of cautious optimism' about the future of stem cell treatment - CollingwoodToday [Last Updated On: October 12th, 2019] [Originally Added On: October 12th, 2019]
Business briefs - News - The Hutchinson News [Last Updated On: November 3rd, 2019] [Originally Added On: November 3rd, 2019]
Canine Arthritis Treatment Market 2018 to Showing Impressive Growth by 2027 | Industry Trends, Share, Size, Top Key Players Analysis and Forecast... [Last Updated On: November 12th, 2019] [Originally Added On: November 12th, 2019]
Global cell therapy market is expected to grow with a healthy CAGR over the forecast period from 2019-2025 - PRNewswire [Last Updated On: November 12th, 2019] [Originally Added On: November 12th, 2019]
Stem of the problem | Columns | Journal Gazette - Fort Wayne Journal Gazette [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
Examining the ethics of embryonic stem cell research ... [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
Must-Reads Of The Week From Brianna Labuskes - Kaiser Health News [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
Bioethics experts call on GoFundMe to ban unproven medical treatments - The Verge [Last Updated On: December 10th, 2019] [Originally Added On: December 10th, 2019]
Automation in Cell Therapy Manufacturing Is Driving the Growth of the Cell Therapy Market over the Forecast Period (2019-2025) - Press Release -... [Last Updated On: December 14th, 2019] [Originally Added On: December 14th, 2019]
Drugs, Biologics, and Regenerative Medicine in 2019: A Successful Year Ends with Promise of a More Challenging 2020 - JD Supra [Last Updated On: December 18th, 2019] [Originally Added On: December 18th, 2019]
Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2018 - BioSpace [Last Updated On: January 7th, 2020] [Originally Added On: January 7th, 2020]
Orthobiology Market Innovative Technologies, Current And Future Trends - PharmiWeb.com [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
Why stem cells could be the medical innovation of the century - World Economic Forum [Last Updated On: January 17th, 2020] [Originally Added On: January 17th, 2020]
Europe's guardian of stem cells and hopes, real and unrealistic - Yahoo News [Last Updated On: January 25th, 2020] [Originally Added On: January 25th, 2020]
Stem cell clinics much-hyped treatments lack scientific support - Science News [Last Updated On: January 31st, 2020] [Originally Added On: January 31st, 2020]
Mystery of Leaky Gut Plumbed by UCSD Team, Which Created Mini-Guts - Times of San Diego [Last Updated On: February 11th, 2020] [Originally Added On: February 11th, 2020]
Health: Is this company onto an alternative to stem cell therapy? - Stockhead [Last Updated On: February 12th, 2020] [Originally Added On: February 12th, 2020]
Canine Stem Cell Therapy Market Recent Trends, In-depth Analysis, Size and Forecast To 2027 | VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus,... [Last Updated On: February 15th, 2020] [Originally Added On: February 15th, 2020]
10 Best Clinics for Stem Cell Therapy in Mexico [2020 Prices] [Last Updated On: February 15th, 2020] [Originally Added On: February 15th, 2020]
Advice on Finding Legitimate Stem Cell Clinics - CBS News [Last Updated On: February 15th, 2020] [Originally Added On: February 15th, 2020]
Global Skin and Wound Care Market Is Expected to Reach USD 25.98 Billion by 2025 : Fior Markets - Yahoo Finance [Last Updated On: March 4th, 2020] [Originally Added On: March 4th, 2020]
Dubai is the 'new Beverly Hills of the Middle East': Here's why - Gulf News [Last Updated On: March 7th, 2020] [Originally Added On: March 7th, 2020]
Best Market Research on Stem Cell Therapy Market, Industry / Sector Analysis Report, Regional Outlook & Competitive Market Share & Forecast,... [Last Updated On: March 9th, 2020] [Originally Added On: March 9th, 2020]
Amyotrophic Lateral Sclerosis Treatment Market Share Forecast to 2027: Orion Pharma, Kringle Pharma, Inc., Aquestive Therapeutics, Apotex Inc, Bausch... [Last Updated On: March 11th, 2020] [Originally Added On: March 11th, 2020]
Future Growth Of Animal Stem Cell Therapy Market By New Business Developments - News by aeresearch [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
Global transcutaneous electrical nerve stimulation market is expected to grow with a healthy CAGR over the forecast period from 2019-2025 - PRNewswire [Last Updated On: March 24th, 2020] [Originally Added On: March 24th, 2020]
Stem Cell Therapy Market is expected to reach US$ 5129.66 million in 2027 - Germany English News [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
Stem Cell Therapy Market to 2027 - Global Analysis and Forecasts by Type; Treatment; Application; End User, and Geography - Baker City Herald [Last Updated On: April 18th, 2020] [Originally Added On: April 18th, 2020]